This video outlines ten common mistakes people make when taking Retatrutide, a triple-agonist medication for weight loss. Dr. Jones explains how Retatrutide differs from other GLP-1 medications due to its action on three receptors (GLP-1, GIP, and glucagon) and how these mistakes can hinder its effectiveness or lead to adverse effects. The video emphasizes the importance of proper dosing, understanding the drug's metabolic impact, and seeking professional supervision.
Here are the 10 mistakes discussed in the video:
Mistake number three is Ignoring Heart Rate.
When taking Retatrutide, it's common for individuals to notice an increase in their resting heart rate by 5, 8, 10, or even more beats per minute. This elevation is largely attributed to the glucagon receptor activation and the overall "triple agonist tax" where activating three receptor systems simultaneously causes the body to work harder, increasing heart rate and internal temperature, and subsequently, calorie burn.
The critical error isn't the elevated heart rate itself, as it's often a manageable and expected side effect. The mistake is ignoring it. Many people don't track their resting heart rate or mention these changes to their healthcare provider, simply pushing through. However, in some patients, this heart rate elevation can be significant enough to warrant holding the dose or adjusting the treatment protocol. In serious cases, medical providers might even decide to pause Retatrutide altogether due to cardiac concerns.
Therefore, it's crucial to monitor your heart rate while on Retatrutide and communicate any significant changes to your provider.